{"database": "openregs", "table": "documents", "rows": [["FDA-2011-N-0003-0011", "FDA", "FDA-2011-N-0003", "Oral Dosages Form New Animal Drugs: Robenacoxib", "Rule", "NFR-Notice of Final Rule", "2011-04-05T04:00:00Z", 2011, 4, "2011-04-05T04:00:00Z", null, "2011-04-05T13:54:22Z", "2011-08053", 0, 0, "0900006480c1bc56"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2011-N-0003-0011"], "units": {}, "query_ms": 0.54518086835742, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}